Dell Technologies R&D increased by 6.0% to $797.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.3%, from $716.00M to $797.00M. Over 4 years (FY 2022 to FY 2026), R&D shows an upward trend with a 5.3% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $619.00M | $697.00M | $650.00M | $593.00M | $681.00M | $626.00M | $677.00M | $694.00M | $688.00M | $705.00M | $692.00M | $513.00M | $763.00M | $780.00M | $745.00M | $716.00M | $808.00M | $785.00M | $752.00M | $797.00M |
| QoQ Change | — | +12.6% | -6.7% | -8.8% | +14.8% | -8.1% | +8.1% | +2.5% | -0.9% | +2.5% | -1.8% | -25.9% | +48.7% | +2.2% | -4.5% | -3.9% | +12.8% | -2.8% | -4.2% | +6.0% |
| YoY Change | — | — | — | — | +10.0% | -10.2% | +4.2% | +17.0% | +1.0% | +12.6% | +2.2% | -26.1% | +10.9% | +10.6% | +7.7% | +39.6% | +5.9% | +0.6% | +0.9% | +11.3% |